Mechanisms of Sympathetic Activation in Obesity-Related Hypertension
Murray Esler(Baker Heart and Diabetes Institute), Élisabeth Lambert(Swinburne University of Technology), Nina Eikelis(Baker Heart and Diabetes Institute), Kazuko Masuo(Baker Heart and Diabetes Institute), Gavin Lambert(Swinburne University of Technology), Nora E. Straznicky(Baker Heart and Diabetes Institute)
Cited by 437
Related Papers
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
|Circulation|1986|1k
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
|Physiological Reviews|1990|792
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
|New England Journal of Medicine|2009|774